Trial Profile
Intensity Modulated Radiotherapy with Simultaneous Boost plus Temozolomide in high grade gliomas.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 31 Oct 2012
Price :
$35
*
At a glance
- Drugs Temozolomide (Primary)
- Indications Glioma
- Focus Therapeutic Use
- 30 Jul 2011 New trial record